The Mount Sinai Alzheimer's Disease Research Center

The Mount Sinai Alzheimer's Disease Research Center (ADRC) operates as a premier research facility and clinical program situated within the Icahn School of Medicine at Mount Sinai in New York, NY. Positioned at 1399 Park Avenue, the center integrates advanced scientific discovery with specialized clinical services to address normal aging, Alzheimer's disease, and related dementias. Its multidisciplinary framework spans clinical trials, translational research, genomic sciences, and a dedicated brain tissue donation program. By focusing on genetics, biological mechanisms, environmental factors, and brain imaging, the center pushes forward the boundaries of neurodegenerative disease research. It actively serves patients, families, and researchers while leading critical studies, such as investigating demographic-specific dementia risks and genetic markers of brain disease, reinforcing its standing as a cornerstone of cognitive healthcare and clinical innovation in Upper Manhattan.

Dedicated to converting scientific breakthroughs into real-world patient care, the center offers vital support resources, educational programming, and clinical trial access to patients and families navigating memory disorders. It plays an active role in training the next generation of clinical scientists through specialized development initiatives, continuing medical education, and fellowship collaborations. Operational reliability is demonstrated through robust research infrastructure, organized data sharing guidelines, and strong grant-funded academic partnerships supported by the National Institutes of Health. By connecting rigorous laboratory research with clinical evaluations and participant-driven studies, the center ensures that participants and caregivers receive high-caliber clinical expertise. Through ongoing research participation, community engagement, and scientific collaboration, the facility remains committed to improving diagnostic precision and advancing therapeutic options for Alzheimer's disease.